Ask AI
ProCE Banner Activity

New Frontiers in PrEP and the Urgent Need for Latin America

Clinical Thought

Despite global progress toward preventing HIV transmission, Latin America faces a rising HIV epidemic. Learn how the WHO’s endorsement of innovations in pre-exposure prophylaxis modalities presented at IAS 2025 could help alleviate the burden of HIV in the Latin American region.

Released: August 06, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Claudia P. Cortes, MD: consultant/advisor/speaker: GlaxoSmithKline, Janssen, Merck, Pfizer.